Patient Resources

The infusion services that Vivo Infusion (formerly ID Consultants) offers include outpatient IV antibiotic therapy and biologic infusions. Below is a list of the most common therapies that we administer, although we can also provide other therapies not included in this list. Visit the official manufacturer website for each therapy to learn more about:

  • How the drug is used to treat certain conditions
  • Possible risks and side effects
  • Financial assistance programs that the manufacturer may offer to help cover the cost of the therapy
  • Additional patient support for your diagnosis
 

ACTEMRA (tocilizumab)

Visit Site

ADAKVEO (crizanlizumab-tmca)

Visit Site

APRETUDE (cabotegravir)

Visit Site

BENLYSTA (belimumab)

Visit Site

CIMZIA (certolizumab)

Visit Site

CINQAIR (reslizumab)

Visit Site

CRYSVITA (burosumab-twza)

Visit Site

ENTYVIO (vedolizumab)

Visit Site

EVENITY (romosozumab-aqqg)

Visit Site

FABRAZYME (agalsidase beta)

Visit Site

FERAHEME (ferumoxytol)

Visit Site

FASENRA (benralizumab)

Visit Site

GAMMAGARD (IVIG)

Visit Site

GIVLAARI (givosiran)

Visit Site

ILUMYA (tildrakizumab-asmn)

Visit Site

INJECTAFER (ferric carboxymaltose injection)

Visit Site

KEYTRUDA (pembrolizumab)

Visit Site

KRYSTEXXA (pegloticase)

Visit Site

LEMTRADA (alemtuzumab)

Visit Site

LEQVIO (inclisiran)

Visit Site

LUMIZYME (algucosidase alfa)

Visit Site

MONOFERRIC (ferric derisomaltose)

Visit Site

NUCALA (mupolizumab)

Visit Site

NULOJIX (belatacept)

Visit Site

OCREVUS (ocrelizumab)

Visit Site

ONPATTRO (patisiran)

Visit Site

OPDIVO (nivolumab)

Visit Site

ORENCIA (abatacept)

Visit Site

PROLASTIN C (alpha-proteinase)

Visit Site

QUTENZA (capsaicin)

Visit Site

REMICADE (infliximab)

Visit Site

RITUXAN (rituximab)

Visit Site

SAPHNELO (anifrolumab-fnia)

Visit Site

SIMPONI ARIA (golimumab)

Visit Site

SKYRIZI (risankizumab-rzaa)

Visit Site

SOLIRIS (eculizumab)

Visit Site

SOLU-MEDROL (methylprednisolone)

Visit Site

STELARA (ustekinumab)

Visit Site

TEPEZZA (teprotumumab-trbw)

Visit Site

TEZSPIRE (tezepelumab-ekko)

Visit Site

THYROGEN (thyrotropin alfa)

Visit Site

TYSABRI (natalizumab)

Visit Site

UPLIZNA (inebilizumab-cdon)

Visit Site

ULTOMIRIS (ravulizumab-cwvz)

Visit Site

VENOFER (iron sucrose)

Visit Site

VYEPTI (eptinezumab)

Visit Site

VYVGART (efgartigimod alfa-fcab)

Visit Site

XOLAIR (omalizumab)

Visit Site